๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Liver Cancer, Adult

Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC NCT06553885Phase 21 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Enfortumab Vedotin Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence NCT06954116Phase 21 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Iparomlimab and Tuvonralimab (QL1706), Partial hepatectomy Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study NCT07806292Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: anlotinib combined with benmelstobart and HAIC RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study NCT07345247n/a20 sites๐Ÿ“ Adana๐Ÿ“ Adana๐Ÿ“ Adana Ankara University Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation? NCT06777017n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment NCT06537193NA1 site๐Ÿ“ Seoul Asan Medical Center ยท Tests: AMRI, CT Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma NCT06911255Phase 1, Phase 21 site๐Ÿ“ Seoul Yoon Jun Kim ยท Tests: Tremelimumab Plus Durvalumab (MEDI4736), Transarterial chemoembolization (TACE) A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites๐Ÿ“ Beverly Hills๐Ÿ“ San Francisco๐Ÿ“ Westwood, Los Angeles Fore Biotherapeutics ยท Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC) NCT07393074NA1 site๐Ÿ“ Lyon Hospices Civils de Lyon ยท Tests: Measurements of autonomic nervous system (ANS) activity at rest and during sensory stimulation., Self-administered quesโ€ฆ QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT NCT07327788Phase 21 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: Iparomlimab and Tuvonralimab Injection (QL1706), Bevacizumab, Hepatic Arterial Infusion Chemotherapy with Raltitrexed aโ€ฆ Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection NCT06219096NA1 site๐Ÿ“ Chengdu West China Hospital ยท Tests: NIF image-guided laparoscopic anatomical liver resection with the novel ICG@HSA administration, NIF image-guided laparoโ€ฆ Recurrent Liver Cancer: Reconceptualization and Reevaluation NCT06430983n/a1 site๐Ÿ“ Nanjing Nanjing Medical University Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging NCT06060769n/a1 site๐Ÿ“ Zhuhai Fifth Affiliated Hospital, Sun Yat-Sen University Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC NCT06726161Phase 1, Phase 213 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Orange RayzeBio, Inc. ยท Tests: RYZ811, RYZ801 SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin NCT07560566Phase 21 site๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: Topical Indomethacin Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance NCT06653062n/a1 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Plasma and Tumor Tissue Mitochondrial DNA (mtDNA) Mutation Analysis Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer NCT04745390NA1 site๐Ÿ“ London London Health Sciences Centre Research Institute OR Lawson โ€ฆ ยท Tests: Radiation therapy Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence NCT07839767n/a1 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: Liver-in-cube testing A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites๐Ÿ“ San Francisco๐Ÿ“ Walnut Creek University of California, San Francisco ยท Tests: Radiation Therapy (RT) SIRT Versus cTACE for Unresectable HCC (CHANCE2506) NCT06909708NA1 site๐Ÿ“ Nanjing Zhongda Hospital ยท Tests: SIRT, cTACE NWRD06 DNA Plasmid for HCC After Curative Resection. NCT07324304Phase 26 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Newish Technology (Beijing) Co., Ltd. ยท Tests: NWRD06 administered by electroporation Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Shanghai GV20 Therapeutics ยท Tests: GV20-0251 Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma NCT05954897Phase 21 site๐Ÿ“ Guangzhou Guangdong Provincial People's Hospital ยท Tests: Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma NCT06339424Phase 21 site๐Ÿ“ Taoyuan City Chang Gung Memorial Hospital ยท Tests: Atezolizumab, Bevacizumab, Photon radiotherapy Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma NCT05842174Phase 1, Phase 21 site๐Ÿ“ Philadelphia VA Office of Research and Development ยท Tests: Hydroxychloroquine, Lipiodol, Placebo Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors NCT07337460Phase 21 site๐Ÿ“ Yangzhou Northern Jiangsu People's Hospital ยท Tests: Icaritin Soft Capsules and mFOLFOX ๏ผšOxaliplatin,leucovorin calcium,5-fluorouracil Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT) NCT07312292Phase 21 site๐Ÿ“ Utrecht Niek Wijnen ยท Tests: Angiotensin II (Giaprezaยฎ), Yttrium-90 radioembolization
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy